BCOR expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.492800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.477200E-01
Normal-vs-Stage2
4.488800E-01
Normal-vs-Stage3
3.665900E-02
Normal-vs-Stage4
7.286200E-01
Stage1-vs-Stage2
9.017700E-02
Stage1-vs-Stage3
1.364100E-02
Stage1-vs-Stage4
9.094200E-01
Stage2-vs-Stage3
1.304020E-01
Stage2-vs-Stage4
1.243790E-01
Stage3-vs-Stage4
1.009590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.473200E-01
Normal-vs-AfricanAmerican
8.903200E-01
Normal-vs-Asian
6.088000E-01
Caucasian-vs-AfricanAmerican
4.352000E-01
Caucasian-vs-Asian
9.839400E-01
AfricanAmerican-vs-Asian
4.126800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.612000E-01
Normal-vs-Female
7.852400E-01
Male-vs-Female
4.912600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.852800E-01
Normal-vs-Age(41-60Yrs)
6.125800E-01
Normal-vs-Age(61-80Yrs)
6.851800E-01
Normal-vs-Age(81-100Yrs)
1.232040E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.546100E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.197600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.535720E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.620400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.772000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.479900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.161800E-01
Normal-vs-Daily Drinker
4.936400E-01
Normal-vs-Weekly Drinker
2.794000E-01
Normal-vs-Occasional Drinker
7.178800E-01
Normal-vs-Social Drinker
4.610600E-01
Non Drinker-vs-Daily Drinker
9.886600E-01
Non Drinker-vs-Weekly Drinker
4.824200E-01
Non Drinker-vs-Occasional Drinker
1.364990E-01
Non Drinker-vs-Social Drinker
9.323600E-01
Daily Drinker-vs-Weekly Drinker
5.589400E-01
Daily Drinker-vs-Occasional Drinker
1.435830E-01
Daily Drinker-vs-Social Drinker
9.334200E-01
Weekly Drinker-vs-Occasional Drinker
8.574100E-02
Weekly Drinker-vs-Social Drinker
4.998000E-01
Occasional Drinker-vs-Social Drinker
1.552650E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.502610E-01
Normal-vs-Grade 2
3.678500E-03
Normal-vs-Grade 3
3.529700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.029380E-01
Grade 1-vs-Grade 3
2.230000E-01
Grade 1-vs-Grade 4
1.502610E-01
Grade 2-vs-Grade 3
4.351600E-01
Grade 2-vs-Grade 4
3.678500E-03
Grade 3-vs-Grade 4
3.529700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.475600E-01
Normal-vs-NonDiabetic
7.164000E-01
Diabetic-vs-NonDiabetic
2.348800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.647000E-01
Normal-vs-NoPancreatitis
6.539200E-01
Pancreatitis-vs-NoPancreatitis
4.525600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.255800E-01
Normal-vs-N1
4.889400E-01
N0-vs-N1
5.268200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.771400E-01
Normal-vs-TP53-NonMutant
8.632200E-01
TP53-Mutant-vs-TP53-NonMutant
8.401800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
